Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats
- PMID: 10439772
- DOI: 10.1097/00000539-199908000-00045
Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats
Abstract
The nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signal pathway plays an important role in anesthetic and analgesic effects. We sought to determine the involvement of inhibition of soluble guanylyl cyclase (sGC) in the anesthetic mechanism and site of action of volatile anesthetics. We examined the effect of intracerebroventricular (ICV) administration of methylene blue (MB), a sGC inhibitor, on the minimum alveolar anesthetic concentration (MAC) of sevoflurane and the brain cGMP content in rats in vivo. We also investigated the effect of sevoflurane on NO-stimulated sGC activity in vitro. The rats were divided into three groups. After the ICV administration of MB, sevoflurane MAC and brain cGMP contents were measured in the first group and the second group, respectively. In the third group, brain cGMP contents were determined after sevoflurane anesthesia without the ICV administration of MB to examine the direct effect of sevoflurane on brain cGMP contents. MB significantly decreased sevoflurane MAC and brain cGMP content in a dose-dependent manner. Sevoflurane itself also dose-dependently decreased cGMP contents in brain in vivo and inhibited the NO-stimulated sGC activity in vitro. These results suggest that the inhibition of the NO-cGMP signal pathway at the sGC level could be involved in anesthetic or analgesic effects, and the inhibitory effect of sevoflurane on sGC would be one of the sites of action of this anesthetic.
Implications: Because the nitric oxide-cyclic guanosine monophosphate signal pathway mediates nociception and the site of action of halogenated volatile anesthetics in uncertain, we examined the possible involvement of inhibition of soluble guanylyl cyclase in the anesthetic mechanism. The inhibitory effect of sevoflurane on soluble guanylyl cyclase could be one of sites of this anesthetic.
Similar articles
-
Halogenated volatile anesthetics inhibit carbon monoxide-stimulated soluble guanylyl cyclase activity in rat brain.Acta Anaesthesiol Scand. 2000 Mar;44(3):321-5. doi: 10.1034/j.1399-6576.2000.440318.x. Acta Anaesthesiol Scand. 2000. PMID: 10714848
-
The soluble guanylyl cyclase inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isoflurane anesthesia in rats.Anesth Analg. 2004 Sep;99(3):752-757. doi: 10.1213/01.ANE.0000132695.77191.F3. Anesth Analg. 2004. PMID: 15333406
-
Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.Eur J Pharmacol. 1998 Jan 26;342(2-3):217-24. doi: 10.1016/s0014-2999(97)01491-x. Eur J Pharmacol. 1998. PMID: 9548389
-
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.Eur Respir Rev. 2024 Mar 20;33(171):230183. doi: 10.1183/16000617.0183-2023. Print 2024 Jan 31. Eur Respir Rev. 2024. PMID: 38508664 Free PMC article. Review.
-
Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.J Cardiovasc Pharmacol. 2016 May;67(5):367-72. doi: 10.1097/FJC.0000000000000330. J Cardiovasc Pharmacol. 2016. PMID: 26452163 Review.
Cited by
-
Intraoperative adjuncts in surgery for primary hyperparathyroidism.Langenbecks Arch Surg. 2009 Sep;394(5):799-809. doi: 10.1007/s00423-009-0532-6. Epub 2009 Jul 10. Langenbecks Arch Surg. 2009. PMID: 19590891 Review.
-
Cellular and molecular actions of Methylene Blue in the nervous system.Med Res Rev. 2011 Jan;31(1):93-117. doi: 10.1002/med.20177. Med Res Rev. 2011. PMID: 19760660 Free PMC article. Review.
-
Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements.Metab Brain Dis. 2000 Dec;15(4):275-85. doi: 10.1023/a:1011171124603. Metab Brain Dis. 2000. PMID: 11383552
-
Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.Psychopharmacology (Berl). 2007 Oct;194(2):271-8. doi: 10.1007/s00213-007-0834-8. Epub 2007 Jun 26. Psychopharmacology (Berl). 2007. PMID: 17593355
-
Gene Expression Profiling Analysis Reveals Putative Phytochemotherapeutic Target for Castration-Resistant Prostate Cancer.Front Oncol. 2019 Aug 2;9:714. doi: 10.3389/fonc.2019.00714. eCollection 2019. Front Oncol. 2019. PMID: 31428582 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous